Colorado Therapeutics Company
Colorado Therapeutics, LLC, (“Company”) a privately held company, is focused on developing xenogenic (sourced from different mammalian species) biologic tissue matrix products for a broad range of soft tissue reinforcement, regenerative, and vascular applications. The Company is leveraging over 15 years of innovative and proprietary tissue processing technology to produce a superior biologic product that combines the benefits of currently available biologic and synthetic products.
Total Funding:
$6 870 367
Last Funding Date:
17.04.2017
Technology:
Specific disorder-related
Estimated Revenue:
<$1 Mn
Founded Date:
01.01.2015
Employee Number:
11-50
Industry:
Treatment range
Headquarters:
Louisville, USA
Funding Status:
N/A
Last Funding Type:
Venture - Series Unknown